Intact mutS in laboratory-derived and clinical glycopeptide-intermediate Staphylococcus aureus strains

Arunachalam Muthaiyan1, Radheshyam K Jayaswal, Brian J Wilkinson

  • 1Microbiology Group, Department of Biological Sciences, Illinois State University, Normal, Illinois 61790-4120, USA.

Insights

Mutations in the mutS gene did not cause vancomycin resistance in Staphylococcus aureus strains. Sequencing confirmed the mutS gene was intact in all parent and intermediate strains studied.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Genetics

Background:

  • Staphylococcus aureus is a significant pathogen.
  • Vancomycin is a critical antibiotic for treating S. aureus infections.
  • The development of vancomycin resistance in S. aureus is a major public health concern.

Purpose of the Study:

  • To investigate the role of the mutS gene in the development of vancomycin resistance in Staphylococcus aureus.
  • To determine if mutations in the mutS gene are associated with vancomycin intermediate resistance.

Main Methods:

  • Sequencing of the mutS gene.
  • Analysis of 10 parent and glycopeptide-intermediate Staphylococcus aureus strains.

Main Results:

  • The mutS gene was found to be intact in all 10 strains analyzed.
  • No mutations were identified in the mutS gene in either parent or vancomycin-intermediate strains.

Conclusions:

  • Mutations in the mutS gene are not responsible for the development of vancomycin resistance in the studied Staphylococcus aureus strains.
  • The methyl-directed mismatch repair system, as assessed by the mutS gene, does not appear to be involved in the emergence of vancomycin resistance in these strains.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...